Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

This study has been completed.
Information provided by:
Ceragenix Pharmaceuticals Identifier:
First received: April 11, 2007
Last updated: February 5, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)